Polyacrylic acid

Polyacrylic acid Structure
Polyacrylic acid
Share to Facebook Share to Twitter Share to Linkedin
Common Name Polyacrylic acid
CAS Number 9003-01-4 Molecular Weight 72.06270
Density 1.09 (30% aq.) Boiling Point 116ºC
Molecular Formula (C3H4O2)n Melting Point 106ºC
MSDSPolyacrylic acid MSDS|SDS|pdf download Chinese USA Flash Point 61.6ºC
Symbol GHS08
GHS08
Signal Word Danger

 Names

[ Name ]: poly(acrylic acid) macromolecule
[ Synonym ]: More Synonyms

 Chemical & Physical Properties

[ Density ]: 1.09 (30% aq.)
[ Boiling Point ]: 116ºC
[ Melting Point ]: 106ºC
[ Molecular Formula ]: (C3H4O2)n
[ Molecular Weight ]: 72.06270
[ Flash Point ]: 61.6ºC
[ Exact Mass ]: 72.02110
[ PSA ]: 37.30000
[ LogP ]: 0.25700
[ Index of Refraction ]: n20/D 1.442

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AT4680000
CHEMICAL NAME :
Acrylic acid, polymers
CAS REGISTRY NUMBER :
9003-01-4
LAST UPDATED :
199710
DATA ITEMS CITED :
14
MOLECULAR FORMULA :
(C3-H4-O2)x
MOLECULAR WEIGHT :
168.06
WISWESSER LINE NOTATION :
/*1Y*VQ/

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ACIEAY Angewandte Chemie, International Edition in English. (VCH Pub., Inc., 303 NW 12th Ave., Deerfield Beach, FL 33441) V.1- 1962- Volume(issue)/page/year: 14,94,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 25,721,1970
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
39 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC 20037) V.6- 1963- Volume(issue)/page/year: 21,652,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
70 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ZMEIAV Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii. Journal of Microbiology, Epidemiology, and Immunology. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.14- 1935- Volume(issue)/page/year: (9),14,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 114,258,1958 *** REVIEWS *** IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 19,47,1979 IARC Cancer Review:Animal No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 19,47,1979 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 82129 No. of Facilities: 2084 (estimated) No. of Industries: 44 No. of Occupations: 55 No. of Employees: 34007 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X7610 No. of Facilities: 31268 (estimated) No. of Industries: 198 No. of Occupations: 162 No. of Employees: 571954 (estimated) No. of Female Employees: 232712 (estimated)

 Safety Information

[ Symbol ]: GHS08
GHS08
[ Signal Word ]: Danger
[ Hazard Statements ]: H340-H350
[ Precautionary Statements ]: P201-P308 + P313
[ Personal Protective Equipment ]: Eyeshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US)
[ Hazard Codes ]: C: Corrosive;T: Toxic;Xi: Irritant;
[ Risk Phrases ]: 45-46-34-36/37/38
[ Safety Phrases ]: S24/25
[ RIDADR ]: UN 3265 8/PG 3
[ WGK Germany ]: 3
[ RTECS ]: AT4680000
[ HS Code ]: 3906909090

 Customs

[ HS Code ]: 3906909090

 Articles35

More Articles
Cyclodextrin-crosslinked poly(acrylic acid): adhesion and controlled release of diflunisal and fluconazole from solid dosage forms.

AAPS PharmSciTech 14(1) , 301-11, (2013)

The controlled release of diflunisal and fluconazole from tablets made of novel polymers, poly(acrylic acid) (PAA) crosslinked with either β-cyclodextrin (βCD) or hydroxypropyl-βCD (HPβCD), was invest...

Cyclodextrin-crosslinked poly(acrylic acid): Synthesis, physicochemical characterization and controlled release of diflunisal and fluconazole from hydrogels.

Int. J. Pharm. 444(1-2) , 175-84, (2013)

The aim of this work was to develop mucoadhesive hydrogels with variable drug delivery properties by crosslinking poly(acrylic acid) (PAA) with cyclodextrins (CDs). CD-PAA polymers with high CD conten...

Chest wall reconstruction using biomaterials.

Ann. Thorac. Surg. 95(3) , 1050-6, (2013)

Skeletal chest wall reconstruction can be a challenge, depending on the indication, location, and health of the patient; various materials are available. Recently, biomaterials that are remodelable (b...